The CEO of Maryland-based Novavax believes U.S. Emergency Use Authorization (EUA) for the company’s protein-based COVID-19 vaccine could happen “within weeks.”

The old adage that drinking beer before wine prevents hangovers turns out to be a myth, German researchers say.